Tropheryma whipplei as a commensal bacterium

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Fenollar F, Puéchal X, Raoult D. Whipple’s disease. N. Engl. J. Med.356,55–66 (2007).▪ Comprehensive and exhaustive review regarding Whipple’s disease.
  Medline CASGoogle Scholar
• 2  Moos V, Schneider T. Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei. Eur. J. Clin. Microbiol. Infect. Dis.10,1151–1158 (2011).
  Google Scholar
• 3  Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Med. (Balt.)89,337–345 (2010).▪ Recent series of patients with several types of chronic infection due to Tropheryma whipplei.
  MedlineGoogle Scholar
• 4  Fenollar F, Mediannikov O, Socolovschi C et al.Tropheryma whipplei bacteremia during fever in rural west Africa. Clin. Infect. Dis.51,515–521 (2010).
  MedlineGoogle Scholar
• 5  Raoult D, Fenollar F, Rolain JM et al.Tropheryma whipplei in children with gastroenteritis. Emerg. Infect. Dis.16,776–782 (2010).
  Medline CASGoogle Scholar
• 6  Fenollar F, Ponge T, La Scola B, Lagier JC, Lefebvre M, Raoult D. First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications. J. Infect.65,275–278 (2011).
  MedlineGoogle Scholar
• 7  Dobbins WO 3rd. Whipple’s Disease. Thomas Books, IL, USA (1987).
  Google Scholar
• 8  Dutly F, Altwegg M. Whipple’s disease and ‘Tropheryma whippelii’. Clin. Microbiol. Rev.14,561–583 (2001).
  Medline CASGoogle Scholar
• 9  Ehrbar HU, Bauerfeind P, Dutly F, Koelz HR, Altwegg M. PCR-positive tests for Tropheryma whippelii in patients without Whipple’s disease. Lancet353(9171),2214 (1999).
  Medline CASGoogle Scholar
• 10  Dutly F, Hinrikson HP, Seidel T, Morgenegg S, Altwegg M, Bauerfeind P. Tropheryma whippelii DNA in saliva of patients without Whipple’s disease. Infection28,219–222 (2000).
  Medline CASGoogle Scholar
• 11  Maibach RC, Dutly F, Altwegg M. Detection of Tropheryma whipplei DNA in feces by PCR using a target capture method. J. Clin. Microbiol.40,2466–2471 (2002).
  Medline CASGoogle Scholar
• 12  Fenollar F, Trani M, Davoust B et al. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J. Infect. Dis.197,880–887 (2008).
  Medline CASGoogle Scholar
• 13  Fenollar F, Trape JF, Bassene H, Sokhna C, Raoult D. Tropheryma whipplei in fecal samples from children, Senegal. Emerg. Infect. Dis.15,922–924 (2009).
  MedlineGoogle Scholar
• 14  Keita AK, Bassene H, Tall A et al.Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl. Trop. Dis.5(12),e1403 (2011).▪ Demonstrates the high prevalence of T. whipplei carriage in rural Senegal, the presence of specific geotypes in Senegal and the high prevalence of specific clones among individuals living in the same village, as well as the high genetic heterogeneity of T. whipplei.
  MedlineGoogle Scholar
• 15  Schoniger-Hekele M, Petermann D, Weber B, Muller C. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl. Environ. Microbiol.73,2033–2035 (2007).
  MedlineGoogle Scholar
• 16  Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A. Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl. Environ. Microbiol.64,760–762 (1998).▪ Reports the presence of T. whipplei in the wastewater of sewage plants.
  Medline CASGoogle Scholar
• 17  La Scola B, Fenollar F, Perreal C, Raoult D. Epidemiologic implications of the first isolation and cultivation of Tropheryma whipplei from a saliva sample. Ann. Intern. Med.154,443–444 (2011).▪ First report showing the viability of T. whipplei in saliva.
  MedlineGoogle Scholar
• 18  Raoult D, Fenollar F, Birg ML. Culture of Tropheryma whipplei from the stool of a patient with Whipple’s disease. N. Engl. J. Med.355,1503–1505 (2006).▪ First report showing the viability of T. whipplei in stool specimens.
  Medline CASGoogle Scholar
• 19  Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull. Johns Hopkins Hosp.18,382–391 (1907).
  CASGoogle Scholar
• 20  Black-Schaffer B. Tinctorial demonstration of a glycoprotein in Whipple’s disease. Proc. Soc. Exp. Biol. Med.72,225–227 (1949).
  Medline CASGoogle Scholar
• 21  Oliver-Pascual E, Galan J, Oliver-Pascual A, Castillo E. [One case of intestinal lipodystrophy with mesenteric adenopathies with granulomatosis lipophagic lesions (Whipple’s disease)]. Rev. Esp. Ap. Dig. Nutr.6,213–226 (1947).
  Medline CASGoogle Scholar
• 22  Rickman LS, Freeman WR, Green WR et al. Brief report: uveitis caused by Tropheryma whippelii (Whipple’s bacillus). N. Engl. J. Med.332,363–366 (1995).
  Medline CASGoogle Scholar
• 23  Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple’s disease. Ann. Neurol.40,561–568 (1996).
  Medline CASGoogle Scholar
• 24  Fenollar F, Nicoli F, Paquet C et al. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis. BMC Infect. Dis.11,171 (2011).
  MedlineGoogle Scholar
• 25  Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J. Clin. Microbiol.35,2733–2739 (1997).
  Medline CASGoogle Scholar
• 26  Altwegg M, Fleisch-Marx A, Goldenberger D, Hailemariam S, Schaffner A, Kissling R. Spondylodiscitis caused by Tropheryma whippelii. Schweiz. Med. Wochenschr.126,1495–1499 (1996).
  Medline CASGoogle Scholar
• 27  Fenollar F, Raoult D. Whipple’s disease. Clin. Diagn. Lab. Immunol.8,1–8 (2001).
  Medline CASGoogle Scholar
• 28  Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple’s disease: new aspects of pathogenesis and treatment. Lancet Infect. Dis.8,179–190 (2008).
  Medline CASGoogle Scholar
• 29  Greub G. A new piece added to the whipple puzzle: Tropheryma whipplei primary infection with bacteremia and cough. Clin. Infect. Dis.51,522–524 (2010).
  MedlineGoogle Scholar
• 30  Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl Acad. Sci. USA104,20529–20533 (2007).
  Medline CASGoogle Scholar
• 31  Bousbia S, Papazian L, Auffray JP et al.Tropheryma whipplei in patients with pneumonia. Emerg. Infect. Dis.16,258–263 (2010).
  MedlineGoogle Scholar
• 32  Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology22,128–133 (1952).
  Medline CASGoogle Scholar
• 33  Cohen A, Schimmel E, Holt P, Isselbacher K. Ultrastructural abnormalities in Whipple’s disease. Proc. Soc. Exp. Biol. Med.105,411–414 (1960).
  Medline CASGoogle Scholar
• 34  Chears WC Jr, Ashworth CT. Electron microscopy study of the intestinal mucosa in Whipple’s disease – demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology41,129–138 (1961).
  MedlineGoogle Scholar
• 35  Yardley JH, Hendrix TR. Combined electron and light microscopy in Whipple’s disease – demonstration of ‘bacillary bodies’ in the intestine. Bull. Johns Hopkins Hosp.109,80–98 (1961).
  Medline CASGoogle Scholar
• 36  Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple’s disease-associated bacterium. Lancet338,474–475 (1991).▪ First evidence of the DNA of a bacterium in samples of patients with Whipple’s disease.
  Medline CASGoogle Scholar
• 37  Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N. Engl. J. Med.327,293–301 (1992).
  Medline CASGoogle Scholar
• 38  Raoult D, Birg M, La Scola B et al. Cultivation of the bacillus of Whipple’s disease. N. Engl. J. Med.342,620–625 (2000).▪ Cultivation and establishment of the first strain of T. whipplei.
  Medline CASGoogle Scholar
• 39  La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple’s disease bacillus. Int. J. Syst. Evol. Microbiol.51,1471–1479 (2001).
  Medline CASGoogle Scholar
• 40  Bentley SD, Maiwald M, Murphy LD et al. Sequencing and analysis of the genome of the Whipple’s disease bacterium Tropheryma whipplei. Lancet361,637–644 (2003).
  Medline CASGoogle Scholar
• 41  Raoult D, Ogata H, Audic S et al.Tropheryma whipplei Twist: a human pathogenic actinobacteria with a reduced genome. Genome Res.13,1800–1809 (2003).
  Medline CASGoogle Scholar
• 42  Street S, Donoghue HD, Neild GH. Tropheryma whippelii DNA in saliva of healthy people. Lancet354,1178–1179 (1999).
  Medline CASGoogle Scholar
• 43  Amsler L, Bauernfeind P, Nigg C, Maibach RC, Steffen R, Altwegg M. Prevalence of Tropheryma whipplei DNA in patients with various gastrointestinal disease and in healthy controls. Infection31,81–85 (2003).
  Medline CASGoogle Scholar
• 44  Fenollar F, Laouira S, Lepidi H, Rolain J, Raoult D. Value of Tropheryma whipplei quantitative PCR assay for the diagnosis of Whipple’s disease: usefulness of saliva and stool specimens for first line screening. Clin. Infect. Dis.47,659–667 (2008).
  MedlineGoogle Scholar
• 45  Fenollar F, Keita AK, Buffet S, Raoult D. High prevalence of Tropheryma whipplei in families of patients and chronic carriers suggests intrafamilial circulation. Emerg. Infect. Dis.18,949–955 (2012).
  MedlineGoogle Scholar
• 46  Maiwald M, von Herbay A, Persing DH et al.Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease. Ann. Intern. Med.134,115–119 (2001).
  Medline CASGoogle Scholar
• 47  Rolain JM, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol.7,48 (2007).
  MedlineGoogle Scholar
• 48  Fenollar F, Birg M L, Gauduchon V, Raoult D. Culture of Tropheryma whipplei from human samples: a 3-year experience (1999 to 2002). J. Clin. Microbiol.41,3816–3822 (2004).
  Google Scholar
• 49  Raoult D, La Scola B, Lecocq P, Lepidi H, Fournier PE. Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease. JAMA285,1039–1043 (2001).
  Medline CASGoogle Scholar
• 50  Maiwald M, von Herbay A, Fredricks DN, Ouverney CC, Kosek JC, Relman DA. Cultivation of Tropheryma whipplei from cerebrospinal fluid. J. Infect. Dis.188,801–808 (2003).
  MedlineGoogle Scholar
• 51  Puechal X, Fenollar F, Raoult D. Cultivation of Tropheryma whipplei from the synovial fluid in Whipple’s arthritis. Arthritis Rheum.56,1713–1718 (2007).
  MedlineGoogle Scholar
• 52  Angelakis E, Fenollar F, Lepidi H, Birg ML, Raoult D. Tropheryma whipplei in the skin of patients with classic Whipple’s disease. J. Infect.61,266–269 (2010).
  MedlineGoogle Scholar
• 53  Renesto P, Crapoulet N, Ogata H et al. Genome-based design of a cell-free culture medium for Tropheryma whipplei. Lancet362,447–449 (2003).
  MedlineGoogle Scholar
• 54  Silva M, Macedo P, Moura Nunes J. Ultrastructure of bacilli and the bacillary origin of the macrophagic inclusions in Whipple’s disease. J. Gen. Microbiol.131,1001–1013 (1961).
  Google Scholar
• 55  Henderson IR, Owen P, Nataro JP. Molecular switches – the ON and OFF of bacterial phase variation. Mol. Microbiol.33,919–932 (1999).
  Medline CASGoogle Scholar
• 56  Maiwald M, Ditton HJ, von Herbay A, Rainey FA, Stackebrandt E. Reassessment of the phylogenetic position of the bacterium associated with Whipple’s disease and determination of the 16S–23S ribosomal intergenic spacer sequence. Int. J. Syst. Bacteriol.46,1078–1082 (1996).
  Medline CASGoogle Scholar
• 57  Hinrikson H, Dutly F, Nair S, Altwegg M. Detection of three different types of ‘Tropheryma whippelii’ directly from clinical specimens by sequencing, single-strand conformation polymorphism (SSCP) analysis and type-specific type PCR of their 16S–23S ribosomal intergenic spacer region. Int. J. Syst. Bacteriol.49,1701–1706 (1999).
  Medline CASGoogle Scholar
• 58  Hinrikson H, Dutly F, Altwegg M. Evaluation of a specific nested PCR targeting domain III of the 23S rRNA gene of ‘Tropheryma whippelii’ and proposal of a classification system for its molecular variants. J. Clin. Microbiol.38,595–599 (2000).
  Medline CASGoogle Scholar
• 59  Gurtler V, Stanisich VA. New approaches to typing and identification of bacteria using the 16S–23S rDNA spacer region. Microbiology142,3–16 (1996).
  MedlineGoogle Scholar
• 60  Hinrikson H, Dutly F, Altwegg M. Homogeneity of 16S–23S ribosomal intergenic spacer regions of Tropheryma whippelii in Swiss patients with Whipple’s disease. J. Clin. Microbiol.37,152–156 (1999).
  Medline CASGoogle Scholar
• 61  Maiwald M, von Herbay A, Lepp PW, Relman DA. Organization, structure, and variability of the rRNA operon of the Whipple’s disease’s bacterium (Tropheryma whippelii). J. Bacteriol.182,3292–3297 (2000).
  Medline CASGoogle Scholar
• 62  Li W, Fenollar F, Rolain JM et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology154,521–527 (2008).
  Medline CASGoogle Scholar
• 63  Fournier PE, Zhu Y, Ogata H, Raoult D. Use of highly variable intergenic spacer sequences for multispacer typing of Rickettsia conorii strains. J. Clin. Microbiol.42,5757–5766 (2004).
  Medline CASGoogle Scholar
• 64  Zhu Y, Fournier PE, Ogata H, Raoult D. Multispacer typing of Rickettsia prowazekii enabling epidemiological studies of epidemic typhus. J. Clin. Microbiol.43,4708–4712 (2005).
  Medline CASGoogle Scholar
• 65  Foucault C, La Scola B, Lindroos H, Andersson SG, Raoult D. Multispacer typing technique for sequence-based typing of Bartonella quintana. J. Clin. Microbiol.43,41–48 (2005).
  Medline CASGoogle Scholar
• 66  Li W, Chomel BB, Maruyama S et al. Multispacer typing to study the genotypic distribution of Bartonella henselae populations. J. Clin. Microbiol.44,2499–2506 (2006).
  Medline CASGoogle Scholar
• 67  Drancourt M, Roux V, Dang LV et al. Orientalis-like Yersinia pestis found by spacer genotyping during historical plague pandemics. Emerg. Infect. Dis.10,1585–1592 (2004).
  Medline CASGoogle Scholar
• 68  Keita A K, Brouqui P, Badiaga S et al.Tropheryma whipplei prevalence strongly suggests human transmission in homeless shelters. Int. J. Infect. Dis. doi:10.1016/j.ijid.2012.05.1033 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 69  Lagier JC, Fenollar F, Lepidi H, Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J. Antimicrob. Chem.66,1188–1189 (2011).
  Medline CASGoogle Scholar
• 70  Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd. Antibiotic treatment and relapse in Whipple’s disease. Long term follow-up of 88 patients. Gastroenterology88,1867–1873 (1985).
  Medline CASGoogle Scholar
• 71  Ruffin JM, Kurtz SM, Roufail WM. Intestinal lipodystrophy (Whipple’s disease); the immediate and prolonged effect of antibiotic therapy. JAMA195,476–478 (1966).
  Medline CASGoogle Scholar
• 72  Garas G, Cheng W, Abrugiato R, Forbes G. Clinical relapse in Whipple’s disease despite maintenance therapy. J. Gastroenterol. Hepatol.15,1223–1226 (2000).
  Medline CASGoogle Scholar
• 73  Schnider PJ, Reisinger EC, Gerschlager W et al. Long-term follow-up in cerebral Whipple’s disease. Eur. J. Gastroenterol. Hepatol.8,899–903 (1996).
  Medline CASGoogle Scholar
• 74  Levy M, Poyart C, Lamarque D, Delchier J C. Whipple’s disease: acquired resistance to trimethoprim–sulfamethoxazole. Am. J. Gastroenterol.95,2390–2391 (2000).
  Medline CASGoogle Scholar
• 75  Bakkali N, Fenollar F, Biswas S, Rolain JM, Raoult D. Acquired resistance to trimethoprim–sulfamethoxazole during Whipple’s disease and expression of the causative target gene. J. Infect. Dis.198,101–108 (2008).
  Medline CASGoogle Scholar
• 76  Fenollar F, Rolain JM, Alric L et al. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int. J. Antimicrob. Agents34,255–259 (2009).
  Medline CASGoogle Scholar
• 77  Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim–sulfamethoxazole in classic Whipple’s disease. J. Antimicrob. Chemother.65,2005–2012 (2010).
  Medline CASGoogle Scholar
• 78  Feurle GE, Moos V, Schneider T, Fenollar F, Raoult D. The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple’s disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole. J. Antimicrob. Chemother.67,1295–1296 (2012).
  Medline CASGoogle Scholar
• 79  Fenollar F, Raoult D. How should classic Whipple’s disease be managed? Nat. Rev. Gastroenterol. Hepatol.7(5),246–248 (2010).
  Medline CASGoogle Scholar
• 80  Uryu K, Sakai T, Yamamoto T et al. Central nervous system relapse of Whipple’s disease. Intern. Med.51,2045–2050 (2012).
  MedlineGoogle Scholar
• 81  Pauletti C, Pujia F, Accorinti M et al. An atypical case of neuro-Whipple: clinical presentation, magnetic resonance spectroscopy and follow-up. J. Neurol. Sci.297,97–100 (2010).
  MedlineGoogle Scholar
• 82  Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple’s disease-tetracyline versus trimethoprim–sulfamethoxazole. Dig. Dis. Sci.39,1642–1648 (1994).
  Medline CASGoogle Scholar
• 83  Cooper GS, Blades EW, Remler BF, Salata RA, Bennert KW, Jacobs GH. Central nervous system Whipple’s disease: relapse during therapy with trimethoprim–sulfamethoxazole and remission with cefexime. Gastroenterology106,782–786 (1994).
  Medline CASGoogle Scholar
• 84  Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob. Agents Chemother.48,747–752 (2004).
  Medline CASGoogle Scholar
• 85  Boulos A, Rolain JM, Mallet MN, Raoult D. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J. Antimicrob. Chemother.55,178–181 (2005).
  Medline CASGoogle Scholar
• 86  Rolain JM, Fenollar F, Raoult D. In vitro activity of pentamidine against Tropheryma whipplei. Int. J. Antimicrob. Agents38,545–547 (2011).
  Medline CASGoogle Scholar
• 87  Ghigo E, Capo C, Aurouze M et al. Survival of Tropheryma whipplei, the agent of Whipple’s disease, requires phagosome acidification. Infect. Immun.70,1501–1506 (2002).
  Medline CASGoogle Scholar
• 88  Masselot F, Boulos A, Maurin M, Rolain J, Raoult D. Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm. Antimicrob. Agents Chemother.47,1658–1664 (2003).
  Medline CASGoogle Scholar
• 89  Bakkali N, Fenollar F, Rolain JM, Raoult D. Comment on: therapy for Whipple’s disease. J. Antimicrob. Chemother.61,968–969 (2008).
  Medline CASGoogle Scholar
• 90  Lepidi H, Fenollar F, Gerolami R et al. Whipple’s disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens. Hum. Pathol.34,589–596 (2003).
  MedlineGoogle Scholar
• 91  Drancourt M, Raoult D, Lepidi H et al. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann. Intern. Med.139,1046–1047 (2003).
  MedlineGoogle Scholar
• 92  Fenollar F, Amphoux B, Raoult D. A paradoxical Tropheryma whipplei western blot differentiates patients with Whipple’s disease from asymptomatic carriers. Clin. Infect. Dis.49,717–723 (2009).
  Medline CASGoogle Scholar
• 93  Dobbins WO 3rd. Whiple’s disease. Mayo Clin. Proc.63,623–628 (1988).
  MedlineGoogle Scholar
• 94  Hur JW, Na YI, Kim TH, Yim SY, Jun JB. The prevalence of Tropheryma whippelii DNA in saliva from healthy controls and patients with spondyloarthropathy. Rheumatol. Int.27,507–508 (2007).
  Medline CASGoogle Scholar
• 95  Zinkernagel A, Gmur R, Fenner L, Schaffner A, Schoedon G, Schneemann M. Marginal and subgingival plaque – a natural habitat of Tropheryma whipplei? Infection31,86–91 (2003).
  Medline CASGoogle Scholar
• 96  Djelouadji Z, Arnold C, Gharbia S, Raoult D, Drancourt M. Multispacer sequence typing for Mycobacterium tuberculosis genotyping. PLoS One3,e2433 (2008).
  MedlineGoogle Scholar
• 97  Van Kruiningen H, Dobbins WO 3rd, John G. Bacterial histiocytic colitis in a lowland gorilla (Gorilla gorilla gorilla). Vet. Pathol.28,554–556 (1991).
  Google Scholar
• 98  Van Kruiningen H, Montalli R, Strandberg J, Kirk R. A granulomatous colitis of dogs with histologic resemblance to Whipple’s disease. Pathol. Vet.2,521–544 (1965).
  Medline CASGoogle Scholar
• 99  Al Moussawi K, Malou N, Mege JL, Raoult D, Desnues B. An experimental mouse model to establish Tropheryma whipplei as a diarrheal agent. J. Infect. Dis.204,44–50 (2011).
  MedlineGoogle Scholar
• 100  Martineti M, Biagi F, Badulli C et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology136,2289–2294 (2009).
  MedlineGoogle Scholar
• 101  Moos V, Schmidt C, Geelhaar A et al. Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology138,210–220 (2010).
  Medline CASGoogle Scholar
• 102  Moos V, Schneider T. The role of T cells in the pathogenesis of classical Whipple’s disease. Expert Rev. Anti Infect. Ther.10,253–255 (2012).
  Medline CASGoogle Scholar